However, during diabetes progression, SUMO-deficient SNS-Ubc9−/− mice exhibited reduced levels of complexes II, III, IV, and V compared to control Ubc9fl/fl mice (Figure 3g, quantification in Figure 3h). This evidence concerns the gene UBE2I and diabetes mellitus.